PRW Wealth Management LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 1,084 shares of the company’s stock, valued at approximately $65,000.
Several other institutional investors also recently bought and sold shares of CL. Victory Capital Management Inc. raised its position in shares of Colgate-Palmolive by 233.4% in the third quarter. Victory Capital Management Inc. now owns 300,554 shares of the company’s stock valued at $20,122,000 after buying an additional 210,412 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Colgate-Palmolive by 120.4% in the third quarter. SG Americas Securities LLC now owns 97,669 shares of the company’s stock valued at $6,539,000 after buying an additional 53,350 shares during the last quarter. MML Investors Services LLC raised its position in shares of Colgate-Palmolive by 52.0% in the third quarter. MML Investors Services LLC now owns 35,203 shares of the company’s stock valued at $2,357,000 after buying an additional 12,045 shares during the last quarter. First Mercantile Trust Co. raised its position in shares of Colgate-Palmolive by 12.8% in the third quarter. First Mercantile Trust Co. now owns 43,510 shares of the company’s stock valued at $2,913,000 after buying an additional 4,951 shares during the last quarter. Finally, Commonwealth Bank of Australia raised its position in shares of Colgate-Palmolive by 19.5% in the third quarter. Commonwealth Bank of Australia now owns 1,728,474 shares of the company’s stock valued at $115,712,000 after buying an additional 282,367 shares during the last quarter. Institutional investors own 75.02% of the company’s stock.
Shares of CL stock opened at $66.25 on Friday. Colgate-Palmolive has a one year low of $57.41 and a one year high of $72.61. The company has a quick ratio of 0.76, a current ratio of 1.14 and a debt-to-equity ratio of 32.25. The company has a market cap of $57.32 billion, a P/E ratio of 22.31, a P/E/G ratio of 4.25 and a beta of 0.78.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The firm had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.78 billion. During the same quarter in the prior year, the business posted $0.75 earnings per share. Colgate-Palmolive’s revenue for the quarter was down 2.1% compared to the same quarter last year. Research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.43 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a yield of 2.60%. Colgate-Palmolive’s dividend payout ratio is 56.57%.
In other Colgate-Palmolive news, SVP John J. Huston sold 1,512 shares of the business’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.29, for a total transaction of $100,230.48. Following the completion of the sale, the senior vice president now directly owns 75,180 shares in the company, valued at $4,983,682.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John T. Cahill sold 5,780 shares of the business’s stock in a transaction that occurred on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the sale, the director now owns 27,820 shares of the company’s stock, valued at $1,793,277.20. The disclosure for this sale can be found here. Insiders have sold 51,700 shares of company stock valued at $3,419,284 in the last ninety days. 1.02% of the stock is currently owned by company insiders.
A number of equities analysts have recently weighed in on the stock. Credit Suisse Group assumed coverage on shares of Colgate-Palmolive in a research report on Wednesday, March 6th. They issued an “underperform” rating for the company. BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and boosted their price objective for the company from $56.00 to $67.00 in a research report on Monday, February 11th. Jefferies Financial Group reissued a “hold” rating and issued a $61.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 1st. Wells Fargo & Co reissued a “hold” rating and issued a $57.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, January 31st. Finally, Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 30th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $65.13.
TRADEMARK VIOLATION NOTICE: This article was reported by Highlight Press and is the sole property of of Highlight Press. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://highlightpress.com/2019/03/15/prw-wealth-management-llc-buys-new-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Read More: Why is the LIBOR significant?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.